Dilyara Nabirova
8 ta ish
Kazakh National Medical University
Treatment Outcomes of Isoniazid-Resistant (Rifampicin Susceptible) Tuberculosis Patients in Uzbekistan, 2017–2018
Zayniddin Sayfutdinov, Ajay Kumar, Dilyara Nabirova +5
MaqolaOchiq kirishTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20210 iqtibosABIP-1323. Forecasting the incidence of acute respiratory infections in Uzbekistan, 2022-2023
Rafail Ibragimov, Dilyara Nabirova, Roberta Horth +1
MaqolaOchiq kirish20250 iqtibosABIP-2202. Immune response after hepatitis B vaccination among healthcare providers in Uzbekistan
Rafail Ibragimov, Roberta Horth, Dilyara Nabirova +2
MaqolaOchiq kirish20250 iqtibosABI